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Many successful animal and plant families have developed 
distinctive biochemical strategies; one of the more unusual ex· 
amples is found in a group of marine gastropods, the cone snails 
(Conus) (1). These animals have evolved a specialized biochem· 
istry of small constrained peptides, the conotoxins. These pep· 
tides are the direct translation products of genes (2). However. 
because they are small enough for direct chemical synthe~is and 
sufficiently constrained for three·dimensional conformation de-
termination, conotoxins bridge protein chemistry and molecular 
genetics. Furthermore, the strategy that the cone snails have 
evolved over millions of years for the generation and design of an 
enormous array of small peptide ligands, eal;h with high affinity 
and specificity for a particular receptor protein target, may be 
adaptable for use in vitro. 
Natural History of Cone Snails 
The focus of this minireview is the small peptides made in the 
venoms of the cone snails (Conus). On a geological time lIcale, 
the true cones are a recently evolved group. The oldest verifiable 
Conus fossils occur well after the Cretaceous extinction (3), an 
event resulting in the disappearance of dinosaurs on land and the 
ammonites in marine environments. Just as the extinction of 
dinosaurs provided an opportunity for the rise of the mammals, 
the extinction of the ammonites was probably a key factor for 
the SUl;cess of Conus. Ammonites were believed to be among 
dominant predators in rich. shallow water marine communities, 
an et:ologica! niche occupied by the cone snails today. The genus 
Conu.s has been expanding at an impressive rate; the -500 living 
species make it perhaps the largest single molluscan genus (see 
Fig. 1). 
Although individual Conus species can be highly speCialized, 
as a whole the genus shows a remarkably broad phylogenetic 
range of prey. At least five different phyla of animals are enven· 
omated by cone snails; there are large numbers of Conu..~ species 
which feed only on polychaete worms, other snails, or fish (4). 
Slow moving snails might not he expected to capture fish suc-
cessfully, but dozens of Conus species eat nothing else. Observing 
a fish ·hunting cone such as Conus striatus capture prey is a 
memorable sight. In the presence of fish, the snail extends its 
long threadlike proboscis which serves as a fishing line. A hollow, 
arrow-shaped tooth is ejected at the tip of the proboscis and is 
used to harpoon the fish (see Fig. 2) and inject the venom. The 
fish typically jerks suddenly after being struck but remains teth· 
ered through the proboscis. A good strike causes the fish to be 
immobilized within 1 or 2 s, unable to use its major fins. Total 
paralysis is effected a few seconds later, but often the fish has 
been engulfed by the snail into its distensible stomach even before 
this has occurred. The potent venom is made in a long duct and 
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expelled u~ing a muscular bulb. Althoug-h the -500 Con~ species 
hunt different prey and have different foraging strategies, all 
inject venom through a harpoon-like tooth to immobilize prey. 
One species, Conus geol4raphus, is so venomous that two-thirds 
of human stinging cases are fatal. 
Overview of Conus Peptides 
The biologically active agents in Conus venoms are unusually 
small peptides, 10-30 amino acids in length. Most pep tides are 
multiply disulfide· bonded; small loops of 1-6 amino acids are 
interspersed between the disulfide-bonded Cys residues. There is 
a large array of different peptides in every venom, and each 
appears to be specifically targeted to a particular receptor. The 
profile shown in Fig. 3 is typically obtained upon analysis of a 
Conus venom fraction; a wide range of biological activities is 
observed. Physiological targets have heen identified for several 
peptides found in Conus venoms (see Table I and Refs. 1 and ,"'). 
However, for most peptides in Conu..~ venoms already biochemi· 
cally characterized (over 70 peptides so far , from 10 venoms), the 
receptor targets remain unknown. The full complexity of any 
Single Conu..1 venom has not yet been determined; there may well 
be over 100 different peptides in the more complex venoms. 
Each Conus species has a venom with a distinct pharmacolog· 
ical profile. For example. a major component of C. Neographus 
venom is conantokin·G, which causes sleep in young mice and 
hyperactivity in older mice and targets to the NMDA 1 receptor 
(6, 7). The venom of another fish hunter, C. striatu..s does not 
exhibit this activity. Conversely, C . . ~triatus venom has a major 
excitotoxin not present in C. geographu..~ venom. Although both 
species make peptides targeted to the acetylcholine receptor and 
to voltage-sensitive calcium channels, each venom has a large 
subset of pharmal;ologically distinct entities. Additional pharo 
macologically active factors from different Conus venoms have 
been described including agents with a.adrenergic (81 and choli· 
nomimetic (9) effects, as well as purified components with potent 
effects on smooth and I;ardiac muscle sY5tems (10-13). No de-
tailed sequence information has yet been published for these, but 
they appear to be distinl;t from the conotoxin classes in Table I. 
Despite the great diversity of pep tides in Con~ venoms, one 
striking structural feature is the pattern of Cye residues. A large 
fraction of Conus peptides exhibits one of three characteristic 
arrangements of cysteine residues: the "standard" 2· loop, 3·loop, 
and 4·loop eonotoxin frameworks (see Table U) . The major 4· 
loop framework (C- - -C- - -CC- - -c- - -C) has been identified 
in over 20 Con~ peptides with a. wide range of pharmacological 
effects. Alternative arrangements. some characteristic of Cys·rich 
peptides in other systems, are not found. For example. an alter· 
native 4·loop framework found in mammalian defensins (14) (C-
- -C- - -C- - -C- - -CC) is not present in any Conu..~ pept ide. 
There are a number of Conu..~ peptides that lack disulfide 
bonding altogether. These may assume specific conformations 
through mechanisms other than multiple disulfide linkages. An 
example are the conantokins. which target to NMDA receptors. 
In these peptides 'Y·carboxyglutamate residues are believed to 
induce an a·helical conformation in the presence of calcium ions 
(I5). Thus, although the great majority of venOm peptides have 
multiple disulfide bonds, there may be alternative strategies for 
stabilizing high affinity binding conformations in a minor frllction 
of Conu..~ peptides. 
Hypervariability of Conotoxin Hom%gs 
Analysis of eDNA clones of conotoxins has led to the conclu· 
sion that a specialized genetic mechanism has evolved in Conu.s 
'Th. ~h"r.viations used are: NMDA. N·methy l ·1H'"Jl~'talc ; HPJ.C, high 
performance liquid chromatography. 
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22068 Minireview: Conotoxins 
FIG. 1. Peptide speciolisls: some of the 
-500 different cone snaiJ species. Ea h 
Conu., species produces a venom with its own 
characteristic set of diverse small constrained 
peptides. AlthouRh most venoms bave not yet 
heen biochemically characterized, each should 
r ield distinctive peptide ligands which spe<:if • 
• cally bind cell·surface receptors or ion chan· 
nels. There is remarkable hypervariability be · 
tween peptide sequences from venoms of dif· 
ferent cone species. Possibly, a similar 
hypervariability generatinll mechanism serves 
to produce the strikingly dJverse shell patterns 
as well. Photograph by Kerry Matz. 
FIG. 2. Top panel. lbe tip of the harpoon· like toolh of Conus obscurus_ The 
barbed, hollow tooth is used for injecting venom into the fish prey. canning 
electron micrograph by Dr. Ed King and Chris Hopkins. Lower panel, a 
specimen of C. stria/", has harpooned a fish which is immobiLized and is being 
drawn toward lhe mouth of the snail. The filled arrow indi.cales the harpoon 
tooth through whicb venom was inje<:ted; lhe empty arrow shows the proboscis 
which has been largely pulled back into lbe mouth of the snail. The structure 
al the lOP of the photograph is the siphon. used by these largely nocturnal 
snails use to locate prey. Photograph by Kerry Matz. 
to generate hypervariabiJity in the loop regions between Cys 
residues of the standard frameworks (see Fig. 4) (I, 2). This may 
explain why conotoxins have highly conserved arrangements of 
cysteine residues; Conus pep tides with new pharmacologic speci· 
ficity and biological roles are most likely to evolve with one of 
the tandard conotoxin frameworks because of the hypervariabil-
ity·generating mechanism. In the Conus peptide system, extreme 
sequence hypervariability is observed between functionally ho· 
mologous conotoxins. The same mechanism that gives rise to the 
wide variety of pharmacologically different conotoxins may also 
be responsible for sequence hypervariability within each pharo 
macological class. A set of peptide ligands from a single genus, 
targeted to the same binding pocket of a particular receptor, 
would normally be expected to be highly conserved in primary 
sequence; instead, a remarkable divergence is found. 
Homologous peptides from two venoms that both target to 
pre ynaptic Ca2+ channels are shown in Table nIA (16). If the 
sequences of these peptides, w·conotoxins G VIA and MVIIA, are 
aligned, less than one· third of the non·cy teine amino acids are 
identical. Furthermore, t he amino acids in corresponding loops 
are strikingly different; for example, w·conotoxin GVlA has 3 
residues of hydroxyproline, whereas w-conotoxin MVUA has 
none. Despite these substantial sequence differences, both w· 
conotoxins target the same subset of calcium channels and elicit 
identical biological effects in most phylogenetic systems (17). 
Presumably, these peptides were both evolved to cause paralysis 
by inhibiting presynaptic ca.lcium channels at fish neuromuscular 
junctions, since both come from fish ·hunting Conus. 
It is noteworthy that most of the amino acids conserved be· 
tween w·conotoxins GVIA and MVIIA are also conserved in a 
peptide with entirely different pharmacological specificity, the 
King-Kong peptide from Conus textile (2, 18). If aLI w·conotoxin 
sequences are aligned, on.!y the 6 cysteine residues and one glycine 
moiety are conserved (see Table Ill); these are all present in the 
King·Kong peptide. Thu , the high binding specificity of w· 
conotoxins for calcium channels at vertebrate presynaptic termini 
must be due to the variable loop sequences and not the amino 
acid residues conserved in both w-conotoxins and the King-Kong 
peptide (such a the Cys framework). 
Considerable polymorphism occurs even in the same venom. 
Two a-conotoxins from C. striatus (19, 20) are shown in Table 
IIIB. The Cys re idues are conserved, but fully two-thirds of the 
other amino acids differ in the two peptides. The hypervariability 
of conotoxin homo logs extends to peptides which a.re not disul · 
fide·bonded. Thus, as shown in Table IIlC, conantokins from two 
different Conus specie ,which are es entialJy identical in biolog· 
ical activity, are highly divergent in primary equence (21). 
TABLE I 
Identified receptor targets of conotoxins 
The detailed sequence of all peptides are shown in Ref. 16. 
Targets identified 
ollage' sensitive Ca" channel 
Acetylcholine receptor 
Voltage· sensitive Na' channel 
Vasopressin receptor 
M DA receplor 
• o. of amino acids. 
Conotoxin example 
from C. aeographus 
",-Conotoxin GVlA 
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Minireview: Conotoxins 22069 
Elut ion t ime (min) 
FIG. :1. An HPLC analysis of a peptide fraction from CO/lUS magus 
venom. A peptide fraction from crude C. mag"",, venOm was ohtained afler sire 
fractionation on Sephade. G· 25 and reverse phase H PLC carried out as 
previm)sly d"scrihed. Each peak was a.sayed by intracranial injection of 0.5-2 
nmnt into mice (a:S:!"iumin~ average absorbance and molecular weight). Symp-
loms obtained are indicated ahove each peak. The two peaks that induce 
shaking are ",·conotoxing; NA _ indicate_ nt' biological activity observed. 
TABLE II 
Major conotoxin frameu'flrh.< 
----------------~ 
Framework 
"4·loop" framework : 
I 2 ~ 4 
c- - -C- - -CC- - -C- - -C 
" :I-Ioop" framework: 
I 2 3 
cc- - -C- - -C- - -cc 




""(:ol1<)toxil1' (e. ~"'ufirophu., . C. magu., ); 
"King-Kong" peptides (C_ lex/i/d 
I' ,Col1 otoxiI1S (e:. ilPngraphu.<) ; ".cratchet" 
peptide (c. !n! i Ie ) 
«·Conotoxins (C. /ieographus, C . • triatw;) 
rr Oetailed ~quencl?" of all example:-! are in Ref. L. 
Conotoxin Sequence Degeneracy and Receptor-Ligand 
Interactions 
Why is it possible for peptides with strikingly different primary 
sequences (such as w-conotoxins GVIA and MVIIA) to target the 
same binding sites? Except for the conserved disulfide frame-
works, which are demonstrably not the primary determinants of 
binding specificity, conotoxin homologs are surprisingly diverse 
in primary sequence. One explanation is that the conotoxin 
surfaces that interact with the receptor target (the "pharmacop· 
hore" in the language of pharmaceutical chemistry) have the 
same conformation despite divergent primary sequences. In this 
view, there are degenerate ways to get congruent conformations, 
and amino acid identity in specific positions is not obligatory. 
Alternatively, ligands the size of conotoxins may interact with 
a "macrosite" on the receptor target that contains a number of 
"microsites." Each microsite could contribute to binding affinity 
upon contact with the ligand. The essence of this hypothesis is 
that only a fraction of all potential microsites actually make focal 
E
k .' 
I ~. g ......... " '0. < <. <, "lcDcDccDcDc 
!., .'.:, i~ J, if I i / .. ~ ,$ , ~.,~ ,~lcG'3cE:Jcc~cc::Jc 
I·'· 3'H. ",,: .:',',' ji ii -" i ,,!jcmcllml!ccmcac 
FIG 4. Evolution of new conotoxins. cl):-;A donin~ has indicated that 
although the ~·tetmin81 .nd of ,hE' conotoxin pre<;urs!lro i. highly conserved, 
the cone sn8ils have .. ~ene\ic mech8nism for introducing rapid sequence 
changes specifically in loops (represented as block bar., in the original peptide-' 
betwef'n cysteine residues. The arrow represent~ the .it~ of proleolytic cleav8~e 
t{l relesHe the mlllure Cys·rich conotoxin (rom a preptopeptide precursor. By 
Hwitching Inup$ between cysteine re~idue. at the gene level (perhaps by a 
cas~ette switching mechanism), three new pe]Jtides could be ~eneraled. The 
('Onservation of both the exci~ed N·terminal preproregion and the Cy, residues 
in the mature toxin probably guatant.;es that .pedfic disulfide b"ndin~ is 
conserved. Hnwever, the new peptides may either h~ve the same pharmacolo~, 
ical specificity or entirely different pharmacolo~ical "pecific ity from the ori~inal 
peptide ilnd from each other. 
TABLE 1II 
Hyper('(lriabilily of C<J7wtoxin .1 
Sequences given are from Refs. 1.17, and 19-::2_1_. ______ _ 
A_ ",·Conotoxins from C geographus and C. magll., 
w.Conotox;n r;VIA 
",·Conotoxin MVlIA 
AA idenlilie~ in 12 
~-conotoxjnf; sequenced 
King-Knnll p""tid .. 
(not an w-cono(oxin) 
CKSPGSSCS~SYNCCRS·CN~YTKRCY·· 
CKGKGAKCSRLMYDCCTGSC~SGK··C· 
C G C CC C C 
WCKQSGEMCNLLDQNCCDGYCrvLV' ·CT 
- --'-::R:-_ -".-c,,-n,-,w-x-in. from C. sniocu.' 










GJ::,.,yYQKMt "tNJ.~"tAEVKKNA ' 
", C·t .. tminal amidetion; f , hydrox)')lroline; "t. "t·carboxygIUlamatp. 
contact with determinants on the conotoxin. Thus, two different 
conotoxins with the ~ame pharmacological specificity could con-
tact a different suhset of microsites within the same macrosite. 
Therefore, a large number of diverse peptide structures could 
potentially bind a macrosite. An important prediction of this 
hypothesis is that pharmacologically homologous conotoxins with 
divergent primary sequences would not be conformationally iden· 
tical, even at the contact surface with the receptor (Fig. 5). 
Conotoxins have great utility for studying cell-surface recep-
tors, particularly in the nervous sytem. I n general. the receptor 
system under study is not the natural physiological target but 
one that is evolutionarily related. For example, ",'-conotoxin G VIA 
is widely used to study mammalian central nervous system cal-
cium channels, but not fiflh calcium channels, the natural target. 
In the macrosite model above, a receptor in the same class as the 
natural target could have many microsites conserved but a subset 
that may have diverged. Only the subset of conotoxin homologs 
with direct focal contact would have altered receptor affinity 
when a particular microsit.e is altered. Thus, a set of conotoxin 
homologs should all bind the natural target with high affinity; if 
tested on an evolutionarily related receptor, the set would not 
behave uniformly but in an eclectic fashion, some with high 
affinity and some not binding at all. There are experimental 
observations consistent with this prediction, i.c, the dramatically 
different behavior of (I·conotoxins GI and 51 on mammalian 
neuromuscular synapses, and of w-conotoxin GVIA and MVIIA 
on amphibian neurotransmission. Such results lend some ere· 
dence to the macrosite model in Fig. 5. However, the two models 
above are nut mutually exclusive; both pharmacuphore confor-
mation degeneracy on the ligand and alternative microsite con -
tacts on the receptor could conceivably contribute to the sequence 
divergence observed between any two con%xin homolog~. 
Perspectives and Future Directions 
At the pTe~ent time, only a few Conu., venoms have been 
surveyed, and even in the best characterized venom, only a minor 
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22070 Minireview: Conotoxin 
FIG 5. The Conus loxin macrosite 
model. A represe nw i ion of 8. receptor binding 
!locke! wil h n number o f mic rosiLes which can 
pOLen I ially make foca l contacts with conot.oxin 
]j~8 nds is . hown. T he di8!(1'a m illusn a les 8 
receptor wil h an endogenous liga.nd agonist 
(an e~a",ple is Ihe acelylcholine recepto r); lhe 
e ndogenou liga nd.q are the orange blobs. and 
I he .l'eliou' reb~on i. lhe agoni l binding si t.e . 
The middle parlel illustrates a conoLoxin -
hloc king endogenous ligand bind ing, nlak ing 
I h ree microsit. loca l cont8('l . A , hown in the 
rillhl pallel, the mac rosile can be a ltem auvely 
occupied by conot.oxins wi th differenl primary 
sequences. ench makin~ a di fferenL subset of 
focal cOIu a Is. In th is wny. even pept ides with 
highly divergent sequence co mpeLe fo r bind-
in g to the same recepLo r pocke!.ln the example 
" hown blue andrren conotoxins s ha re twO 
foco l cOntac , wh ile .~ch shares one with the 
purpl conotoxin. All I hrec would serve as 
onl<lgoni.ts of Ihis recept or. 
fraction of peptides has been biochemically or pharmacologically 
haracterized. However, ihis data base still permits a number of 
generalizations. First, there is remarkable pharmacological and 
biochemical diversity of small con t.rained peptides in each Conu 
venom. In Conus leographus venom, mall peptide ligand target 
calcium channels, sodium channels, acetylcholine receptors, and 
NMDA receptors. Even more int riguing are the much larger 
number of biologically active peptides in the same venom for 
which receptor have not ye been identified. 
ln addition to the peptide diver ity in an individual venom, an 
amazing . equence hypervariability be ween venoms is observed. 
o two Conus pecie have ye been found with the same cono-
toxin sequence_ The present data base is best for the paralytic 
conotoxins' it seems reasonable to expect that every Conus venom 
will contain conotoxins directly paralytic to the prey. One obviou 
class of paralytics i conotoxin which inhibi acetylcholine recep-
tor at neuromu cular junctions. lIch agent have been described 
in all fi h-hunting species examined and are very likely found in 
worm-hunting and mollusc-hunting Conus venom as well. How-
ever, the \.ox ins in fi h-hunting pecie are pre urn ably selected 
to inhibit fis h acetylcholine receptors, while the corresponding 
toxins in the venoms of vermivorou Con.us specie would interact 
optimally with worm receptor . We can extrapolate from the data 
already collected that an acetylcholine receptor-targeted cono-
toxin in onepecie will have a ignificantly different equence 
from that in any another Conus species. Thus, for the genus as a 
whole, there should be literally over a thousand different small 
peptide targeted to acetylcholine receptors. Tt eem likely that 
large sets of Con.us peptides will be similarly targeted to many 
other receptors and ion channels. 
The pharmacological potentiaJ of uch sub tantial collections 
of small con trained peptides targeting to one class of receptors 
is immense. The acetylcholine receptor-targeted peptides can be 
ested on variou acety lcholine receptor in djfferent phylogenetic 
systems, such as the set of neuronal receptors in mammalian 
brain . While we cannot predict which peptide in the collection 
will have high affinity for a particular mammalian central nervous 
system acetylcholine receptor subtype, the natural repertoire of 
conotoxin hould provide a rich source of ligands for discrimi-
nating between different receptor target subtype . 
As more information i collected about conotoxin design and 
ynthesis in the natural system it becomes increasingly feasible 
to apply imilar t rategie to gene.rate conotoxin-like molecules 
in.. vitro. One particularly promising approach is to combine 
conotoxin biochemistry with newly developed peptide screening 
methods such as the ru E phage-peptide library technique of 
Scott and Smith (22). Recently, it wa shown tha the addition 
of a conotoxin moduJe as a fusion to a phage coat protein did not 
a ffect phage viabili y (23). Thus, it i feasible to clone billions of 
conotoxin-like sequence onto vector like lU E phage and creen 
Lhe library of conotoxin -like modules for interaction wi th cloned 
receptor targets. The phage that do exhibi t affinity for the recep-
tor target can then be amplified, the D A sequenced, and the 
predicted disulfide-rich conotox.in -Iike peptide synthesized and 
tested for hindinl; \.0 the receptor t(IIgeL. Modification experi -
ments to determine the focal contact points with the receptor are 
also fea ible. Screens for conotoxins with any pharmacological 
specificity desired can be ea i1y designed, i.e. small peptides that 
have very high affinity for one receptor subtype but which do not 
bind other closely related subtypes at all. Since these peptides 
will be con trained conformationally because of multiple disulfide 
bonds, their three-dimensional conformation could then be ana-
lyzed. Thi opens the door to pure chemical applications; for 
example, appropriate peptidomimetic derivative can then be 
designed. The combination of a molecular genetic approach to 
allow screening of billions of sequences with the insight provided 
by the conotoxin y tem bridge molecular genetics and chemistry 
in a way that should permit exciting futu.re application in the 
pharmaceutical industry and many other areas of biotechnology. 
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